Source: Annual Congress 2010 - PG4 Core Curriculum Postgraduate Course: Pathology for the clinician



Rating:

Share or cite this content

Citations should be made in the following way:
P. Dorfmuller (Le Plessis Robinson, France). Pulmonary hypertension: what does the pathology tell us?. Annual Congress 2010 - PG4 Core Curriculum Postgraduate Course: Pathology for the clinician

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hypertension: what can we learn from studies? Source: International Congress 2015 – Practising personalised medicine: why, when, and how? Year: 2015 Image-based recommendations for the evaluation of pulmonary embolism and arterial hypertension: what? when? how? Source: Virtual Congress 2020 – Image-based guidelines and recommendations in respiratory diseases Year: 2020 Assessing risk in pulmonary arterial hypertension: what we know, what we don't Source: Eur Respir J, 50 (2) 1701353; 10.1183/13993003.01353-2017 Year: 2017 Pathophysiology of pulmonary hypertension: what the interested clinician needs to know Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020 What can the ECG tell us about pulmonary embolism? Source: Eur Respir J 2004; 24: Suppl. 48, 274s Year: 2004 What's it like to live with idiopathic pulmonary fibrosis? Ask the experts Source: Eur Respir J 2016; 47:1324-1326 Year: 2016 Cleaning agents and asthma: what does the epidemiology really tell us? Source: International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health? Year: 2018 What we need to tell the patient with lung disease wanting to dive Source: Annual Congress 2011 - Live and let dive: diving and lung health Year: 2011 Clinical trials in pulmonary arterial hypertension: what do they tell us Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018 Clinical trials in pulmonary arterial hypertension: what do they tell us Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2017 Clinical trials in pulmonary arterial hypertension: what they tell us Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020 Debating the new haemodynamic definition of pulmonary hypertension: much ado about nothing? Source: Eur Respir J, 54 (2) 1901278; 10.1183/13993003.01278-2019 Year: 2019 Sex differences in pulmonary hypertension: are we cleaning up the mess? Source: Eur Respir J 2016; 47: 390-393 Year: 2016 Thrombo-embolic pulmonary hypertension: which treatment should we choose? / Hypertension pulmonaire thrombo-embolique: quel traitement choisir ? Source: International Congress 2018 – French Programme 2018: Part II Year: 2018 Reply to: Malnutrition in idiopathic pulmonary fibrosis: the great forgotten comorbidity! Source: Eur Respir J, 53 (5) 1900615; 10.1183/13993003.00615-2019 Year: 2019 Pathology: what do we actually want to know? Source: Annual Congress 2008 - Multidisciplinary approach in interstitial lung disease Year: 2008 Inflammation in pulmonary arterial hypertension: is it time to quell the fire? Source: Eur Respir J 2014; 43: 685-688 Year: 2014